HIV-1 p17 Protein
-
- Target See all HIV-1 p17 products
- HIV-1 p17 (Human Immunodeficiency Virus 1 Matrix (HIV-1 p17))
- Protein Type
- Recombinant
- Origin
- Human Immunodeficiency Virus (HIV)
- Source
- Escherichia coli (E. coli)
- Characteristics
-
Purified recombinant HIV1 p17 protein
Expression System: E.coli - Purity
- > 90 % pure
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Lyophilized from 150 mM NaCl, 50 mM citrate sodium, pH 6.5, no preservatives.
- Preservative
- Without preservative
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C until reconstitution. Following reconstitution aliquot and freeze at -70 °C for long term storage.
-
- Target
- HIV-1 p17 (Human Immunodeficiency Virus 1 Matrix (HIV-1 p17))
- Alternative Name
- HIV1 p17 (HIV-1 p17 Products)
- Target Type
- Viral Protein
- Background
-
HIV1 p17 is the matrix protein of the Gag polyprotein which performs highly complex tasks during the assembly, budding, maturation, and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag precursors also function during viral assembly to selectively bind and package two plus strands of genomic RNA. .
Alternative Names: HIV1 p17, HIV 1 p17 protein, HIV 1 p17 protein, HIV-1 p17 protein, HIV-1 p17, Human Immunodeficiency Virus 1 protein, HIV 1 p17, HIV1 matrix protein p17 protein, Matrix protein p17 protein, HIV-1 p17 protein, MA protein, p17 protein
-